Human‐mouse lymphoid chimeras: host‐vs.‐graft and graft‐vs.‐host reactions

Human peripheral blood lymphocytes (huPBL) were injected into mice with severe combined immune deficiency (SCID). It was ascertained that murine natural killer (NK) cellswere capable of affecting engraftment of human lymphocytesin SCID mice. The presence of host NK cells resulted in the clearance of the human lymphocytes. Human T lymphocyteswere the primary cell to engraft in the SCID recipients, with human T cells being detected in the spleen, lymph nodes, bone marrow and peritoneal cavity of the mice up to several months after transfer. No human T cells were detected in the murine thymus and thelevel of engraftment in the periphery could be highly variable. Additionally, there appeared to be significant reactions between the human lymphocytes and the murine host resulting in a xenogeneic graft‐vs.‐host reaction (XGVHR). The predominant manifestation involved splenomegaly resulting from an expansion of murine hematopoietic cells in the spleens of these xenogeneic chimeras. The severity of the XGVHR could be correlated with the extent of human T cell engraftment and the recovered human Tcells were found to be in a proliferative state. Thus, there appear to be significant host‐vs.‐graft and graft‐vs.‐host interactionsoccurring in human/mouse lymphocyte chimeras.

[1]  D. Longo,et al.  Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. , 1991, Journal of immunology.

[2]  B. Haynes,et al.  Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens , 1991, The Journal of experimental medicine.

[3]  V. Praloran,et al.  Alterations in the expression of colony-stimulating factor-1 and its receptor during an acute graft-vs-host reaction in mice. , 1990, Journal of immunology.

[4]  C. Robinson,et al.  Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice , 1990, The Journal of experimental medicine.

[5]  J. Guardiola,et al.  Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells , 1990, The Journal of experimental medicine.

[6]  M. Gershwin,et al.  Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice , 1989, The Journal of experimental medicine.

[7]  K. Pfeffer,et al.  Adoptive transfer of human peripheral blood lymphocytes (PBL) in scid mice. , 1989, Current topics in microbiology and immunology.

[8]  J. Dick,et al.  Engraftment of immune-deficient mice with human hematopoietic stem cells. , 1988, Science.

[9]  I. Weissman,et al.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. , 1988, Science.

[10]  Donald E. Mosier,et al.  Transfer of a functional human immune system to mice with severe combined immunodeficiency , 1988, Nature.

[11]  W. Murphy,et al.  Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection , 1987, The Journal of experimental medicine.

[12]  M. Bennett,et al.  Biology and genetics of hybrid resistance. , 1987, Advances in immunology.

[13]  I. Weiler,et al.  Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency , 1986, Cell.

[14]  S. Pals,et al.  Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. , 1984, Immunology today.